Phase 2 Clinical Trial of CartiLife® in the United States
NCT04744402
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
25
Enrollment
INDUSTRY
Sponsor class
Conditions
Articular Cartilage Defect
Articular Cartilage Degeneration
Interventions
DRUG:
Autologous Chondrocyte Implantation (CartiLife®)
Sponsor
Biosolution Co., Ltd.